Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 62332-792

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 62332-792). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine-structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, depicting its molecular arrangement including a cyclohexanol ring, methoxyphenyl group, and a dimethylaminoethyl side chain, with hydrochloride indicated as a separate entity.*

FDA Label Image

Figue 1 (Venlafaxine 1 Figure)

A scatter plot chart showing fold changes with 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax and AUC) across various special populations and conditions, including hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis represents change relative to the reference value.*

FDA Label Image

Figure 2 (Venlafaxine 2 Figure)

A forest plot chart depicting the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its analyte in the presence of various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The chart shows the relative change compared to a reference value for each drug interaction.*

FDA Label Image

Figure 3 (Venlafaxine 3 Figure)

A scatter plot chart depicting the fold change and 90% confidence intervals for various analytes interacting with different drugs. The chart plots fold change relative to a reference value on the horizontal axis and lists multiple interacting drugs with their corresponding analytes, pharmacokinetic parameters (Cmax, AUC), and fold changes with error bars.*

FDA Label Image

30 Capsules (Venlafaxine mg 37 5)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg by Alembic Pharmaceuticals Inc., containing 30 capsules. The label includes dosage strength, pharmacist dispensing instructions, storage conditions, bar code, and manufacturer details including Alembic Pharmaceuticals Limited, Gujarat, India.*

FDA Label Image

30 Capsules (Venlafaxine mg 75)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, oral dosage form. The label shows it is manufactured by Alembic Pharmaceuticals Inc. and contains 30 capsules. It includes cautionary notes about child resistance, usual dosage referencing accompanying information, and directions for pharmacists to dispense the medication guide separately. The label also features the NDC number 62332-793-30 and a barcode.*

FDA Label Image

30 Capsules (Venlafaxine mg 150)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg, in capsule form. The label indicates the product is manufactured by Alembic Pharmaceuticals Inc. It includes dosage and storage instructions, barcode, and a package count of 30 capsules. The label emphasizes pharmacy dispensing guidelines and indicates child-resistant packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.